Science & Medicine
Our medicines
Our medicines are for the approved indications for which they are authorized in the local country or region.
This page lists European product trade names with accompanying generic names. Trade and generic names may differ in other markets.
Links to more details on the European Medicines Agency’s (EMA) website are provided for those products that have been granted a centralized marketing authorization by the European Commission.
In compliance with regulations, we cannot provide detailed information about our prescription medicines on this website.
Healthcare professionals and patients can – where applicable – visit local LEO Pharma websites or consult the European Medicines Agency for more information about our medicines.
Always ask a healthcare professional for advice about medicines.
Disease Areas
Atopic Dermatitis
Adtralza®
tralokinumab
Protopic®
tacrolimus
Psoriasis
Kyntheum®
brodalumab
Spevigo®
spesolimab
Chronic Hand Eczema
Anzupgo®
delgocitinib
Critical Care
Loqtorzi®
toripalimab
Marketed by LEO Pharma in Europe under license from Junshi Biosciences
Note
Some LEO Pharma products (such as Enstilar®, Daivobet®, Daivonex®, innohep® orFucidin®) are authorized through national procedures and are not listed in the EMA centralized database. For information about these products, please consult your local LEO Pharma website or healthcare professional.